Quick Facts
  • pin location icon
    Primary Location:
    Lung Institute at Baylor College of Medicine
  • wavy circle icon with check mark inside
    Expertise:
    Research
  • magnifying glass with heart icon
    Speciality:
    Medical Oncology
  • gender symbols interlocked icon
    Gender:
    Female
  • chat box with different language translations icon
    Language:
    English
  • certificate with a ribbon icon below
    Med School:
    University of Colorado Denver School of Medicine

Sabichi is involved in experimental therapeutics of lung, head and neck cancers. She helped investigate a clinical trial involving bevacizumab in the treatment of head and neck cancers. Bevacizumab, also known by brand name Avastin, was recently added to the National Comprehensive Cancer Network’s first-line mesothelioma treatment recommendations.

Contact Dr. Anita Lyn Sabichi
medical stethoscope icon
By submitting, you agree to our privacy policy and disclaimer. Our Patient Advocates may contact you via phone, email and/or text.

Sabichi, who has been in practice for more than 20 years, graduated from the University of Colorado School of Medicine. She completed her residency at New York Presbyterian Hospital and her fellowship at the National Institutes of Health Clinical Center.

In 2021, Dr. Sabichi published a research study on anti-PD-1 monotherapy, outlining the clinical benefits as first-line therapy for malignant pleural mesothelioma patients.

people watching webinar on computer
Browse Our Free Mesothelioma Webinars
group of people holding money
Access More than $32 Billion in Trust Funds
scientists in laboratory
Find Active Mesothelioma Clinical Trials